FDA Drug Recalls

Recalls / Class III

Class IIID-823-2013

Product

Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count bottle (NDC 0591-0737-05), Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA92880.

Affected lot / code info
Lot # a) 444971A, Exp 8/13; b) 444973A, Exp 8/13

Why it was recalled

Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.

Recalling firm

Firm
Watson Laboratories Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
132 Business Center Dr, N/A, Corona, California 92880-1724

Distribution

Quantity
1,260 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-07-19
FDA classified
2013-07-25
Posted by FDA
2013-07-31
Terminated
2014-07-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-823-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls